↓ Skip to main content

Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease

Overview of attention for article published in BMC Neurology, September 2013
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease
Published in
BMC Neurology, September 2013
DOI 10.1186/1471-2377-13-113
Pubmed ID
Authors

Ji Young Yun, Han-Joon Kim, Jee-Young Lee, Young Eun Kim, Ji Seon Kim, Jong-Min Kim, Beom S Jeon

Abstract

Ropinirole prolonged release (RPR) is a once-daily formulation. However, there may be individual pharmacokinetic differences so that multiple dosing may be preferred in some individuals. This study compares once-daily and twice-daily RPR in patients with Parkinson's disease.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
Unknown 56 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 16%
Student > Bachelor 9 16%
Student > Master 8 14%
Student > Ph. D. Student 5 9%
Student > Postgraduate 3 5%
Other 8 14%
Unknown 16 28%
Readers by discipline Count As %
Medicine and Dentistry 18 31%
Neuroscience 6 10%
Agricultural and Biological Sciences 5 9%
Nursing and Health Professions 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 4 7%
Unknown 19 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 September 2013.
All research outputs
#15,278,165
of 22,719,618 outputs
Outputs from BMC Neurology
#1,480
of 2,424 outputs
Outputs of similar age
#122,137
of 198,166 outputs
Outputs of similar age from BMC Neurology
#37
of 53 outputs
Altmetric has tracked 22,719,618 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,424 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,166 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.